US 10464989
Polypeptides, cells, and methods involving engineered CD16
granted A61KA61K2039/505A61K2239/31
Quick answer
US patent 10464989 (Polypeptides, cells, and methods involving engineered CD16) held by Regents of the University of Minnesota expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61K2239/31, A61K2239/38, A61K2239/59